Literature DB >> 9285082

Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.

D L Walker1, M Davis.   

Abstract

Previous studies have shown that the amplitude of the acoustic startle reflex is increased by the presentation of aversive stimuli. In the present study, the amplitude of acoustic startle in rats was increased by exposure to high illumination levels. The effect was directly related to the intensity (0, 8, 70, and 700 footlamberts) of illumination (experiment I); was blocked by the anxiolytic compound buspirone (experiment II); and showed little or no habituation with repeated testing (experiment III). These results suggest that the elevation of startle amplitude by light may reflect an unconditioned anxiogenic effect of high illumination levels. The possible utility of this phenomenon as an animal model of anxiety is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285082     DOI: 10.1016/S0006-3223(96)00441-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  57 in total

1.  Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans.

Authors:  Christian Grillon; Jeremy Cordova; Louise R Levine; Charles A Morgan
Journal:  Psychopharmacology (Berl)       Date:  2003-04-23       Impact factor: 4.530

2.  Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.

Authors:  Kiersten S Smith; Edward G Meloni; Karyn M Myers; Ashlee Van't Veer; William A Carlezon; Uwe Rudolph
Journal:  Psychopharmacology (Berl)       Date:  2010-10-05       Impact factor: 4.530

3.  Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat.

Authors:  Kathryn R Hefner; John J Curtin
Journal:  J Psychopharmacol       Date:  2011-09-21       Impact factor: 4.153

4.  Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.

Authors:  David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould
Journal:  Biol Psychiatry       Date:  2010-08-17       Impact factor: 13.382

5.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

6.  Alcohol stress response dampening during imminent versus distal, uncertain threat.

Authors:  Kathryn R Hefner; Christine A Moberg; Laura Y Hachiya; John J Curtin
Journal:  J Abnorm Psychol       Date:  2013-08

Review 7.  Interaction between startle and voluntary reactions in humans.

Authors:  Josep Valls-Solé; Hatice Kumru; Markus Kofler
Journal:  Exp Brain Res       Date:  2008-05-06       Impact factor: 1.972

Review 8.  Developmental rodent models of fear and anxiety: from neurobiology to pharmacology.

Authors:  Despina E Ganella; Jee Hyun Kim
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

10.  Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.

Authors:  Sayamwong E Hammack; Joseph Cheung; Kimberly M Rhodes; Kristin C Schutz; William A Falls; Karen M Braas; Victor May
Journal:  Psychoneuroendocrinology       Date:  2009-01-31       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.